Evidence map›Paper›PMID 23467085›Full record

ArticleNature2013

Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1.

Chuan Wu, Nir Yosef, Theresa Thalhamer, Chen Zhu, Sheng Xiao, Yasuhiro Kishi, Aviv Regev, Vijay K Kuchroo

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Nature, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04398550 (Specific Carbohydrate Diet vs. Mediterranean Diet Therapy in Ulcerative Colitis - A Clinical Trial), which is not on this map. Cited by 619 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
619citing papers in PubMed, 1 pooled it
42.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04398550 naunknown statusnot on this mapstarted 2020, after this paper: background citation

Specific Carbohydrate Diet vs. Mediterranean Diet Therapy in Ulcerative Colitis - A Clinical Trial

TypeinterventionalSponsorMassachusetts General HospitalRan2020 to 2023Enrolled50ConditionsUlcerative ColitisArmsSpecific Carbohydrate Diet, Mediterranean Diet
3 · Its place in the literature

Who cites it

619 citing papers in PubMed, 1 synthesis or guideline pooled it, 995 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2022
    Trial
  6. Review
  7. Beyond the guidelines: Vascular function as the central determinant and therapeutic target in hypertension.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Review
  8. Review
  9. Article
  10. Review
  11. Salt and chronic kidney disease.Nature reviews. Nephrology · 2026
    Review
  12. Review
  13. Article
  14. Contextualizing TNature reviews. Immunology · 2026
    Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Assessing T-Cell Profile Shifts through IL-23 Inhibition by Guselkumab on Psoriasis.JID innovations : skin science from molecules to population health · 2026
    Article
  20. Review

559 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Chuan WuCenter for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
Nir Yosef
Theresa Thalhamer
Chen Zhu
Sheng Xiao
Yasuhiro Kishi
Aviv Regev
Vijay K Kuchroo
Harvard University · USBrigham and Women's Hospital · USMassachusetts Institute of Technology · US

Funding

TCR recognition of MHC class II peptide compexes in multiple sclerosisP01AI045757 · NIAID · DANA-FARBER CANCER INSTITUTE · PI KUCHROO, VIJAY K., LOVE, JOHN CHRISTOPHER · 1999 to 2017
$22.8M
Transgenic / Knock-out mouse coreP01AI073748 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI BEHAR, SAMUEL M · 2008 to 2019
$17.1M
Center for Cell CircuitsP50HG006193 · NHGRI · BROAD INSTITUTE, INC. · PI REGEV, AVIV · 2011 to 2015
$15.6M
GenomeSpace: A community web environment for integrative genomic analysisP01HG005062 · NHGRI · BROAD INSTITUTE, INC. · PI MESIROV, JILL P. · 2009 to 2013
$9.1M
Role of Th1 specific cell surface molecule Tim-3 in EAE.R01NS045937 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI KUCHROO, VIJAY K. · 2003 to 2016
$4.9M
T CELL RESPONSE TO MYELIN PROTEOLIPID PROTEINR01NS030843 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI KUCHROO, VIJAY K. · 1998 to 2019
$4.1M
The temporal reconfiguration of regulatory networks: From yeast to cancerDP1OD003958 · OD · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI REGEV, AVIV · 2008 to 2011
$3.3M
T cell response to myelin proteolipid proteinR37NS030843 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI KUCHROO, VIJAY K. · 2002 to 2008
$2.6M
The temporal reconfiguration of regulatory networks: From yeast to cancerDP1CA174427 · NCI · BROAD INSTITUTE, INC. · PI REGEV, AVIV · 2012 to 2012
$839k
The role of Tim-1 in immune regulation and autoimmunityK01DK090105 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI XIAO, SHENG · 2011 to 2015
$796k
TCELL RESPONSE TO MYELIN PROTEOLIPID PROTEINR29NS030843 · NINDS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI KUCHROO, VIJAY K · 1992 to 1996
–
Howard Hughes Medical InstituteNCI NIH HHS DP1 CA174427NHGRI NIH HHS 1P01HG005062-01NHGRI NIH HHS 1P50HG006193-01NHGRI NIH HHS P01 HG005062NHGRI NIH HHS P50 HG006193NIAID NIH HHS AI045757NIAID NIH HHS AI073748NIAID NIH HHS P01 AI045757NIAID NIH HHS P01 AI073748NIDDK NIH HHS K01 DK090105NIDDK NIH HHS K01DK090105NIH HHS DP1 OD003958NIH HHS DP1-OD003958-01NINDS NIH HHS NS030843NINDS NIH HHS NS045937NINDS NIH HHS R01 NS030843NINDS NIH HHS R01 NS045937NINDS NIH HHS R29 NS030843NINDS NIH HHS R37 NS030843
6 · The paper itself

Abstract

TH17 cells (interleukin-17 (IL-17)-producing helper T cells) are highly proinflammatory cells that are critical for clearing extracellular pathogens and for inducing multiple autoimmune diseases. IL-23 has a critical role in stabilizing and reinforcing the TH17 phenotype by increasing expression of IL-23 receptor (IL-23R) and endowing TH17 cells with pathogenic effector functions. However, the precise molecular mechanism by which IL-23 sustains the TH17 response and induces pathogenic effector functions has not been elucidated. Here we used transcriptional profiling of developing TH17 cells to construct a model of their signalling network and nominate major nodes that regulate TH17 development. We identified serum glucocorticoid kinase 1 (SGK1), a serine/threonine kinase, as an essential node downstream of IL-23 signalling. SGK1 is critical for regulating IL-23R expression and stabilizing the TH17 cell phenotype by deactivation of mouse Foxo1, a direct repressor of IL-23R expression. SGK1 has been shown to govern Na(+) transport and salt (NaCl) homeostasis in other cells. We show here that a modest increase in salt concentration induces SGK1 expression, promotes IL-23R expression and enhances TH17 cell differentiation in vitro and in vivo, accelerating the development of autoimmunity. Loss of SGK1 abrogated Na(+)-mediated TH17 differentiation in an IL-23-dependent manner. These data demonstrate that SGK1 has a critical role in the induction of pathogenic TH17 cells and provide a molecular insight into a mechanism by which an environmental factor such as a high salt diet triggers TH17 development and promotes tissue inflammation.

Indexed as

AnimalsCell DifferentiationEncephalomyelitis, Autoimmune, ExperimentalForkhead Box Protein O1Forkhead Transcription FactorsHEK293 CellsHumansImmediate-Early ProteinsInterferon-gammaInterleukin-17MicePhenotypePhosphorylationProtein Serine-Threonine KinasesReceptors, InterleukinSerum-Glucocorticoid Regulated KinasesForkhead Box Protein O1Forkhead Transcription FactorsFoxo1 protein, mouseImmediate-Early ProteinsInterferon-gammaInterleukin-17interleukin-23 receptor, mouseProtein Serine-Threonine KinasesReceptors, InterleukinSerum-Glucocorticoid Regulated KinasesSodium ChlorideSodium Chloride, Dietary

Identifiers

PMID23467085
PMCPMC3637879
OpenAlexW2112837750

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.